Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

147
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
147
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

126
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
126
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

542
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
542
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

141
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic DBNDD1-GDF15 Signaling Activates the NF-κB Pathway to Promote Colorectal Cancer Progression.

Molecular cancer research : MCR·2025
Same author

C-Reactive Protein: The Most Familiar Stranger.

Journal of immunology (Baltimore, Md. : 1950)·2023
Same author

Plasma miR-1273g-3p acts as a potential biomarker for early Breast Ductal Cancer diagnosis.

Anais da Academia Brasileira de Ciencias·2020
Same author

Reversible promoter methylation determines fluctuating expression of acute phase proteins.

eLife·2020
Same author

Intra-subunit Disulfide Determines the Conversion and Structural Stability of CRP Isoforms.

Inflammation·2019
Same author

In vitro generation and bioactivity evaluation of C-reactive protein intermediate.

PloS one·2018

Related Experiment Video

Updated: Jun 11, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K

C-Reactive Protein Is Not the Driver Factor in Ulcerative Colitis.

Zhong-Bo Ge1, Xin-Yun Zhang1, Chun-Miao Zhang1

  • 1MOE Key Laboratory of Cell Activities and Stress Adaptations School of Life Sciences Lanzhou University, Lanzhou, Gansu 730000, China.

Gastroenterology Research and Practice
|October 9, 2024
PubMed
Summary

C-reactive protein (CRP) does not appear to directly cause ulcerative colitis in mice. This study suggests CRP may be an indicator, not a driver, of the disease, warranting further human research.

Keywords:
C-reactive proteinCRP-deficient miceulcerative colitis

More Related Videos

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

3.8K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

826

Related Experiment Videos

Last Updated: Jun 11, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
08:58

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

12.2K
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

3.8K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

826

Area of Science:

  • Immunology
  • Gastroenterology
  • Biochemistry

Background:

  • C-reactive protein (CRP) is a nonspecific marker for inflammation.
  • Its role in ulcerative colitis (UC) progression and treatment efficacy is under investigation.
  • Current evidence lacks strong support for CRP directly influencing UC advancement.

Purpose of the Study:

  • To investigate the direct role of C-reactive protein (CRP) in the pathogenesis of ulcerative colitis (UC).
  • To evaluate if CRP deficiency impacts the severity and progression of DSS-induced colitis in a mouse model.

Main Methods:

  • Established a dextran sulfate sodium (DSS)-induced ulcerative colitis mouse model using CRP-deficient and wild-type mice.
  • Assessed phenotypic parameters: body weight, colon length, spleen weight.
  • Evaluated colon histopathology, inflammatory factor expression, and intestinal mucus layer integrity.

Main Results:

  • CRP deficiency did not significantly alter the phenotype, physiological, or biochemical indices of DSS-induced colitis.
  • Antibiotic treatment to control gut microbiota did not reveal significant variations in CRP-deficient mice.
  • Survival rates were comparable between CRP-deficient and wild-type mice.

Conclusions:

  • C-reactive protein (CRP) may not directly mediate ulcerative colitis.
  • CRP is likely a marker of inflammation rather than a causative factor in this model.
  • Further research is needed to clarify CRP's role in human UC due to mouse model limitations.